BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Apyx Medical
APYX
$173M
| $12.9M | ﹤0.01% |
1,971,719
-18,374
| -0.9% | -$181K |
|
3402
Riverview Bancorp
RVSB
$107M
| $12.8M | ﹤0.01% |
1,696,504
+23,551
| +1% | +$180K |
|
|
OYST
3403
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $12.7M | ﹤0.01% |
1,091,834
-33,680
| -3% | -$401K |
|
3404
Crawford & Co Class A
CRD.A
$532M
| $12.7M | ﹤0.01% |
1,680,538
+18,988
| +1% | +$144K |
|
3405
Oric Pharmaceuticals
ORIC
$1.15B
| $12.7M | ﹤0.01% |
2,373,900
-41,447
| -2% | -$373K |
|
3406
Teekay
TK
$1.01B
| $12.6M | ﹤0.01% |
3,989,909
+5,682
| +0.1% | +$18.4K |
|
3407
Deutsche Bank
DB
$69B
| $12.6M | ﹤0.01% |
999,640
+31,771
| +3% | +$423K |
|
|
NYXH
3408
Nyxoah
NYXH
$140M
| $12.6M | ﹤0.01% |
659,270
-11,763
| -2% | -$237K |
|
3409
Vitamin Cottage Natural Grocers
NGVC
$739M
| $12.6M | ﹤0.01% |
641,910
-35,645
| -5% | -$591K |
|
3410
iShares MSCI Kokusai Fund
TOK
$249M
| $12.5M | ﹤0.01% |
129,026
+65,424
| +103% | +$6.26M |
|
3411
PUT
State Street SPDR S&P Retail ETF
XRT
$449M
| $12.5M | ﹤0.01% |
165,000
+5,000
| +3% | +$398K |
|
3412
Superior Group of Companies
SGC
$185M
| $12.5M | ﹤0.01% |
697,578
-10,327
| -1% | -$205K |
|
3413
SES AI
SES
$203M
| $12.4M | ﹤0.01% |
+1,370,893
| New | +$10.3M |
|
|
EPZM
3414
DELISTED
Epizyme, Inc
EPZM
| $12.4M | ﹤0.01% |
10,778,038
+3,162,390
| +42% | +$5.16M |
|
3415
American Outdoor Brands
AOUT
$155M
| $12.4M | ﹤0.01% |
943,498
-25,325
| -3% | -$408K |
|
3416
Stereotaxis
STXS
$126M
| $12.4M | ﹤0.01% |
3,314,654
-26,759
| -0.8% | -$126K |
|
3417
Kopin
KOPN
$652M
| $12.4M | ﹤0.01% |
4,884,355
+1,839
| +0% | +$5.29K |
|
3418
Procept Biorobotics
PRCT
$1.06B
| $12.3M | ﹤0.01% |
352,791
+31,486
| +10% | +$758K |
|
|
GOOS
3419
Canada Goose Holdings
GOOS
$872M
| $12.2M | ﹤0.01% |
465,058
+2,086
| +0.5% | +$59.9K |
|
3420
Hims & Hers Health
HIMS
$6.43B
| $12.2M | ﹤0.01% |
2,286,315
-29,385
| -1% | -$145K |
|
|
BZUN
3421
Baozun
BZUN
$167M
| $12.2M | ﹤0.01% |
1,420,010
+54,082
| +4% | +$598K |
|
3422
ClearPoint Neuro
CLPT
$448M
| $12.2M | ﹤0.01% |
1,169,853
-6,502
| -0.6% | -$59.2K |
|
|
DCBO
3423
Docebo
DCBO
$525M
| $12.1M | ﹤0.01% |
233,933
+74,702
| +47% | +$3.84M |
|
|
ZY
3424
DELISTED
Zymergen Inc. Common Stock
ZY
| $12.1M | ﹤0.01% |
4,192,794
+58,103
| +1% | +$247K |
|
3425
PubMatic
PUBM
$585M
| $12.1M | ﹤0.01% |
463,028
+45,281
| +11% | +$1.16M |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.